Glow-in-the-dark dye could help surgeons spot hidden cancer cells
NCT ID NCT07279116
First seen Jan 08, 2026 · Last updated Apr 28, 2026 · Updated 14 times
Summary
This early-phase trial tests a fluorescent dye called ABY-029 that makes cancer cells glow during surgery. The goal is to find the right dose so surgeons can better see and remove head and neck tumors. About 24 adults with operable head and neck cancer will receive a tiny amount of the dye before surgery. Researchers will check safety and how well the dye highlights cancer tissue compared to healthy tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.